Momelotinib Dose-Intensity is Maintained in JAK Inhibitor-Naive and Previously JAK Inhibitor-Treated Intermediate-/High-Risk Myelofibrosis Patients

Gupta, V; Egyed, M; Hus, M; Kirgner, I; Lech-Maranda, E; Mayer, J; Mead, A; McLornan, D; Nagy, Z; Oh, S; Platzbecker, U; Ross, D; Trelinski, J; Verstovsek, S; Xicoy, B; Yoon, SS; Smith, G; Kowalski, M; Mesa, R

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020; 20 (): S330

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索